Clinical Trials
Molecular Insight Pharmaceuticals is currently enrolling clinical trials throughout the U.S. to evaluate the safety and efficacy of Ultratrace lobenguane l 131 in patients with malignant relapsed/refractory pheo/paraganglioma.
For more information, please contact:
Jennifer Conley, MA, MBA
Clinical Project ManagerMolecular Insight Pharmaceuticals, Inc.
160 Second StCambridge, MA 02142
Tel: 617-871-6635
US National Institutes of Health http://clinicaltrials.gov/ct2/show/nct01377532
Additional Clinical Trials
Additional clinical trials currently recruiting patients with pheochromocytoma and paraganglioma can be found through clinicaltrials.gov
Learn more about paraganglioma >
